Integer price target raised to $150 from $140 at Truist

Truist analyst Richard Newitter raised the firm’s price target on Integer (ITGR) to $150 from $140 and keeps a Buy rating on the shares. Integer beat estimates in Q1 on EPS and organic revenue amid strength in Cardio and Vascular, and guidance for 8%-10% organic growth for fiscal 2025 was reiterated, while EPS guidance was increased, the analyst tells investors in a research note. Truist thinks the outlook leaves room for upside as the year progresses and continues to believe that the company can profitably grow above its end markets.